What does a low iron percentage saturation and ferritin level near the lower end of normal indicate in a 33-year-old active female with a normal Complete Blood Count (CBC), iron level of 61, normal Total Iron Binding Capacity (TIBC) of 419, and normal ferritin level of 31?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Iron Status Interpretation in a 33-Year-Old Active Female

These labs indicate early iron depletion (low iron stores) without anemia, characterized by a low transferrin saturation of 15% despite normal ferritin at 31 ng/mL, which warrants iron supplementation to prevent progression to iron deficiency anemia. 1

Understanding the Lab Values

Your patient's iron panel reveals:

  • Transferrin saturation of 15% is definitively low (normal threshold >20%), indicating insufficient iron available for red blood cell production 2
  • Ferritin of 31 ng/mL sits at the lower end of normal range for women (average 43 μg/L in US women), representing early depletion of iron stores 1
  • Normal CBC confirms this is non-anemic iron deficiency (NAID), where iron stores are depleted but hemoglobin remains normal 2

Clinical Significance

The transferrin saturation is the most clinically important finding here. 3, 4

  • A TSAT <20% is the most reliable indicator of true iron deficiency, more so than ferritin alone 3, 4
  • Recent evidence demonstrates that low TSAT (not ferritin) predicts clinical outcomes and identifies patients who benefit from iron repletion 3, 4
  • Ferritin of 31 ng/mL represents approximately 310 mg of stored iron (each 1 μg/L = ~10 mg stored iron), which is depleted but not yet critically low 1

Why This Matters in an Active Female

Premenopausal women are at high risk for iron depletion due to menstrual blood loss, and active individuals have increased iron demands. 2

  • The combination of menstruation and athletic activity creates ongoing iron losses that exceed dietary intake 2
  • Even without anemia, low iron stores can impair exercise capacity and cause fatigue 2
  • A ferritin <45 μg/L in the context of low TSAT warrants consideration of iron supplementation 2

Recommended Management

Initiate oral iron supplementation now to replenish iron stores before anemia develops. 1

Iron Supplementation Protocol:

  • Ferrous sulfate 200 mg three times daily is first-line therapy 1
  • Continue treatment for three months after any symptoms resolve to fully replenish iron stores 1
  • Recheck iron studies (ferritin and TSAT) after 3 months of therapy 1

When to Investigate Further:

In premenopausal women with NAID, gastrointestinal investigation is generally NOT warranted unless: 2

  • GI symptoms are present (abdominal pain, change in bowel habits, blood in stool)
  • Family history of GI malignancy or celiac disease
  • Failure to respond to adequate oral iron supplementation
  • Progressive worsening despite treatment

The low threshold for investigation applies primarily to men, postmenopausal women, or those with concerning symptoms 2

Important Caveats

Ferritin is an acute-phase reactant - if your patient has any concurrent inflammation, infection, or chronic disease, the ferritin of 31 ng/mL may actually mask more severe iron deficiency 2, 1

  • Consider checking CRP or ESR if there's any clinical suspicion of inflammation 1
  • In the presence of inflammation, iron deficiency may exist even with ferritin levels up to 50-100 μg/L 1

The transferrin saturation of 15% is the definitive finding that confirms functional iron deficiency regardless of the ferritin level 3, 4

Expected Response to Treatment

With appropriate oral iron supplementation:

  • TSAT should normalize (>20%) within 2-3 months 1
  • Ferritin should increase to >50 μg/L, ideally >100 μg/L 1
  • Symptoms (if present) should improve within weeks 1

If no response occurs after 3 months of adequate oral iron, consider: 2

  • Non-compliance or inadequate dosing
  • Malabsorption (celiac disease screening with tissue transglutaminase antibodies)
  • Ongoing blood loss exceeding replacement
  • Need for GI evaluation at that point

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.